Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Sep 18, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000138.pdf
0001714899-23-000138.rtf
0001714899-23-000138.xls
Sep 14, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
0001921094-23-000675.pdf
0001921094-23-000675.rtf
0001921094-23-000675.xls
Aug 24, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000136.pdf
0001714899-23-000136.rtf
0001714899-23-000136.xls
Aug 24, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000137.pdf
0001714899-23-000137.rtf
0001714899-23-000137.xls
Aug 22, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
0001921094-23-000572.pdf
0001921094-23-000572.rtf
0001921094-23-000572.xls
Aug 22, 2023 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
0001921094-23-000573.pdf
0001921094-23-000573.rtf
0001921094-23-000573.xls
Aug 22, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000133.pdf
0001714899-23-000133.rtf
0001714899-23-000133.xls
Aug 22, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000134.pdf
0001714899-23-000134.rtf
0001714899-23-000134.xls
Aug 22, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000132.pdf
0001714899-23-000132.rtf
0001714899-23-000132.xls
Aug 22, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001714899-23-000135.pdf
0001714899-23-000135.rtf
0001714899-23-000135.xls
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Displaying 1 - 10 of 538 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2023 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2023 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use